Pacific Biosciences Of California (PACB) Assets Average (2010 - 2026)
Pacific Biosciences Of California (PACB) posted quarterly Assets Average of $783.2 million for Q1 2026, down 26.15% year-over-year from $1.1 billion in Q1 2025, and down 1.31% quarter-over-quarter from $793.6 million in Q4 2025.
Pacific Biosciences Of California (PACB) Assets Average (2010 - 2026) Analysis & Trends
Pacific Biosciences Of California's Assets Average history runs 17 years deep, the most recent figure standing at $783.2 million for Q1 2026.
- In Q1 2026, Assets Average fell 26.15% year-over-year to $783.2 million; the TTM figure through Mar 2026 stood at $783.2 million (down 26.15% YoY), while the FY2025 annual figure was $1.0 billion, down 32.0% from the prior year.
- Assets Average for Q1 2026 stood at $783.2 million, down from $793.6 million in the prior quarter.
- The five-year high for Assets Average was $2.0 billion in Q1 2022, with the low at $783.2 million in Q1 2026.
- The 5-year median for Assets Average is $1.7 billion (2024), against an average of $1.5 billion.
- The sharpest annual moves came in 2022 and 2025: Assets Average surged 195.85% in 2022, then plunged 46.96% in 2025.
- Pacific Biosciences Of California's Assets Average stood at $1.8 billion in 2022, then grew by 1.63% to $1.8 billion in 2023, then fell by 25.62% to $1.4 billion in 2024, then slumped by 41.44% to $793.6 million in 2025, then dropped by 1.31% to $783.2 million in 2026.
- Business Quant data shows PACB's Assets Average at $783.2 million in Q1 2026, $793.6 million in Q4 2025, and $814.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 109.82 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 47.11 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 92.26 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 44.78 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 13.59 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 6.54 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 37.19 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 31.48 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 10.74 Bn |
| 10 | Pacific Biosciences Of California | 396.09 Mn | 159.21 Mn | 12.64 Mn | 767.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 767.11 Mn |
| Mar 31, 2026 | 783.22 Mn |
| Dec 31, 2025 | 793.62 Mn |
| Sep 30, 2025 | 814.31 Mn |
| Jun 30, 2025 | 843.13 Mn |
| Mar 31, 2025 | 1.06 Bn |
| Dec 31, 2024 | 1.36 Bn |
| Sep 30, 2024 | 1.48 Bn |
| Jun 30, 2024 | 1.59 Bn |
| Mar 31, 2024 | 1.71 Bn |
| Dec 31, 2023 | 1.82 Bn |
| Sep 30, 2023 | 1.87 Bn |
| Jun 30, 2023 | 1.87 Bn |
| Mar 31, 2023 | 1.83 Bn |
| Dec 31, 2022 | 1.79 Bn |
| Sep 30, 2022 | 1.85 Bn |
| Jun 30, 2022 | 1.91 Bn |
| Mar 31, 2022 | 1.97 Bn |
| Dec 31, 2021 | 1.01 Bn |
| Sep 20, 2021 | 624.49 Mn |